A GWAS of CSF soluble TREM2 (sTREM2) by Deming et al. suggested that protective MS4A gene cluster variants increased CSF sTREM2, which was associated with reduced AD risk and a delayed age-at-onset [180]. Here, TREM2 is linked to Alzheimer disease.